Langer drug delivering biopolymer maker raises $25M

Paris' Gecko Biomedical has raised $25 million in support of its drug delivering biopolymer platform for tissue reconstruction. Co-financed by MIT's Robert Langer, the company is aiming to earn its first approval within a year, for a cardiovascular reconstruction candidate. More from FierceMedicalDevices

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.